Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895818721> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2895818721 endingPage "637" @default.
- W2895818721 startingPage "631" @default.
- W2895818721 abstract "Abstract Background Therapeutic Plasma Exchange (TPE) and Intravenous Immunoglobulin both are first‐line treatments for Guillain Barre Syndrome; however, there is a significant difference in cost. We undertook this study to assess the cost minimization for treating Guillain Barre Syndrome patients. Methods A prospective randomized controlled trial was undertaken, in which 40 Guillain Barre Syndrome (GBS) patients with a GBS disability score of grade four and five were enrolled. A societal perspective was adopted for the analysis and assessment of both the health system cost and out‐of‐pocket expenditures. Cost‐minimization analysis was undertaken as both the treatments were equally effective at the end of 12 weeks. Results No statistically significant differences were observed in the GBS Disability scores during overall treatment course in both treatment groups. The Out‐of‐pocket cost for the immunoglobulin (IVIG) group was INR 219 247 (4298 USD) and for the TPE group was INR 104 070 (2040.5 USD). Overall INR 86 685 ($1700), that is, 53% higher cost was observed in IVIG group without any concomitant health outcome benefit. Conclusion In comparison with IVIG, TPE appears to be the better option for treatment of GBS in cost‐constraint countries like ours to provide an economic treatment option to most average people." @default.
- W2895818721 created "2018-10-26" @default.
- W2895818721 creator A5017059841 @default.
- W2895818721 creator A5021929665 @default.
- W2895818721 creator A5022535224 @default.
- W2895818721 creator A5071690494 @default.
- W2895818721 creator A5080397832 @default.
- W2895818721 creator A5084341808 @default.
- W2895818721 creator A5087291567 @default.
- W2895818721 date "2018-10-17" @default.
- W2895818721 modified "2023-09-30" @default.
- W2895818721 title "Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin" @default.
- W2895818721 cites W1984947236 @default.
- W2895818721 cites W2003728556 @default.
- W2895818721 cites W2025484687 @default.
- W2895818721 cites W2027589803 @default.
- W2895818721 cites W2034395916 @default.
- W2895818721 cites W2037008838 @default.
- W2895818721 cites W2040050809 @default.
- W2895818721 cites W2046009630 @default.
- W2895818721 cites W2053218676 @default.
- W2895818721 cites W2063531554 @default.
- W2895818721 cites W2064309062 @default.
- W2895818721 cites W2080582088 @default.
- W2895818721 cites W2095788709 @default.
- W2895818721 cites W2107132506 @default.
- W2895818721 cites W2118700683 @default.
- W2895818721 cites W2120702906 @default.
- W2895818721 cites W2163550872 @default.
- W2895818721 cites W2164537921 @default.
- W2895818721 cites W2516105881 @default.
- W2895818721 doi "https://doi.org/10.1002/jca.21646" @default.
- W2895818721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30329175" @default.
- W2895818721 hasPublicationYear "2018" @default.
- W2895818721 type Work @default.
- W2895818721 sameAs 2895818721 @default.
- W2895818721 citedByCount "16" @default.
- W2895818721 countsByYear W28958187212019 @default.
- W2895818721 countsByYear W28958187212020 @default.
- W2895818721 countsByYear W28958187212021 @default.
- W2895818721 countsByYear W28958187212022 @default.
- W2895818721 countsByYear W28958187212023 @default.
- W2895818721 crossrefType "journal-article" @default.
- W2895818721 hasAuthorship W2895818721A5017059841 @default.
- W2895818721 hasAuthorship W2895818721A5021929665 @default.
- W2895818721 hasAuthorship W2895818721A5022535224 @default.
- W2895818721 hasAuthorship W2895818721A5071690494 @default.
- W2895818721 hasAuthorship W2895818721A5080397832 @default.
- W2895818721 hasAuthorship W2895818721A5084341808 @default.
- W2895818721 hasAuthorship W2895818721A5087291567 @default.
- W2895818721 hasConcept C126322002 @default.
- W2895818721 hasConcept C187212893 @default.
- W2895818721 hasConcept C195244886 @default.
- W2895818721 hasConcept C2778691916 @default.
- W2895818721 hasConcept C2779384505 @default.
- W2895818721 hasConcept C2781072439 @default.
- W2895818721 hasConcept C2910749824 @default.
- W2895818721 hasConcept C2991810699 @default.
- W2895818721 hasConcept C71924100 @default.
- W2895818721 hasConcept C95457728 @default.
- W2895818721 hasConceptScore W2895818721C126322002 @default.
- W2895818721 hasConceptScore W2895818721C187212893 @default.
- W2895818721 hasConceptScore W2895818721C195244886 @default.
- W2895818721 hasConceptScore W2895818721C2778691916 @default.
- W2895818721 hasConceptScore W2895818721C2779384505 @default.
- W2895818721 hasConceptScore W2895818721C2781072439 @default.
- W2895818721 hasConceptScore W2895818721C2910749824 @default.
- W2895818721 hasConceptScore W2895818721C2991810699 @default.
- W2895818721 hasConceptScore W2895818721C71924100 @default.
- W2895818721 hasConceptScore W2895818721C95457728 @default.
- W2895818721 hasIssue "6" @default.
- W2895818721 hasLocation W28958187211 @default.
- W2895818721 hasLocation W28958187212 @default.
- W2895818721 hasOpenAccess W2895818721 @default.
- W2895818721 hasPrimaryLocation W28958187211 @default.
- W2895818721 hasRelatedWork W1975381126 @default.
- W2895818721 hasRelatedWork W1984309643 @default.
- W2895818721 hasRelatedWork W1993347465 @default.
- W2895818721 hasRelatedWork W2106653639 @default.
- W2895818721 hasRelatedWork W2219852335 @default.
- W2895818721 hasRelatedWork W2470410461 @default.
- W2895818721 hasRelatedWork W2895818721 @default.
- W2895818721 hasRelatedWork W3040203698 @default.
- W2895818721 hasRelatedWork W3204107508 @default.
- W2895818721 hasRelatedWork W4221070417 @default.
- W2895818721 hasVolume "33" @default.
- W2895818721 isParatext "false" @default.
- W2895818721 isRetracted "false" @default.
- W2895818721 magId "2895818721" @default.
- W2895818721 workType "article" @default.